Pharmacology and Therapeutics Education in the European Union Needs Harmonization and Modernization:A Cross-sectional Survey Among 185 Medical Schools in 27 Countries by Brinkman, D. J. et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pharmacology and Therapeutics Education in the European
Union Needs Harmonization and Modernization
Citation for published version:
Brinkman, DJ, Tichelaar, J, Okorie, M, Bissell, L, Christiaens, T, Likic, R, Maciulaitis, R, Costa, J, Sanz, EJ,
Tamba, BI, Maxwell, SR, Richir, MC, van Agtmael, MA & Educ Working Grp European A 2017,
'Pharmacology and Therapeutics Education in the European Union Needs Harmonization and
Modernization: A Cross-sectional Survey Among 185 Medical Schools in 27 Countries' Clinical
pharmacology and therapeutics, vol. 102, no. 5, pp. 815-822. DOI: 10.1002/cpt.682
Digital Object Identifier (DOI):
10.1002/cpt.682
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Clinical pharmacology and therapeutics
Publisher Rights Statement:
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs
License, which permits use and distribution in any medium, provided the original work is properly cited, the use
is non-commercial and no modifications or adaptations are made.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
Pharmacology and Therapeutics Education in
the European Union Needs Harmonization and
Modernization: A Cross-sectional Survey Among
185 Medical Schools in 27 Countries
DJ Brinkman1,2, J Tichelaar1,2, M Okorie3, L Bissell3, T Christiaens4, R Likic5, R Macˇıulaitis6, J Costa7,
EJ Sanz8, BI Tamba9, SR Maxwell10, MC Richir1,2, MA van Agtmael1,2; for the Education Working Group
of the European Association for Clinical Pharmacology and Therapeutics (EACPT)
Effective teaching in pharmacology and clinical pharmacology and therapeutics (CPT) is necessary to makemedical
students competent prescribers. However, the current structure, delivery, and assessment of CPT education in the
European Union (EU) is unknown.We sent an online questionnaire to teachers with overall responsibility for CPT education
in EUmedical schools. Questions focused on undergraduate teaching and assessment of CPT, and students’ preparedness
for prescribing. In all, 185medical schools (64%) from 27 EU countries responded. Traditional learningmethods were
mainly used. Themajority of respondents did not provide students with the opportunity to practice real-life prescribing and
believed that their students were not well prepared for prescribing. There is a marked difference in the quality and quantity
of CPT education within and between EU countries, suggesting that there is considerable scope for improvement. A collabo-
rative approach should be adopted to harmonize andmodernize the undergraduate CPT education across the EU.
Study Highlights
WHAT IS THE CURRENT KNOWLEDGE ON THE
TOPIC?
 A previous study showed that few teaching hours in Europe-
an medical schools were devoted to clinical pharmacology and
that there is a lack of trained individuals in this area. Addition-
ally, a recent study showed that the prescribing competencies of
ﬁnal-year medical students in Europe were poor, resulting in
many potentially harmful prescribing errors.
WHAT QUESTION DID THIS STUDY ADDRESS?
 This international multicenter study investigated the current
structure, delivery and assessment of pharmacology and clinical
pharmacology and therapeutics (CPT) education in European
Union (EU) medical schools.
WHAT THIS STUDY ADDS TO OUR KNOWLEDGE?
 There is marked variation in the quality and quantity of
CPT education within and between EU countries. CPT teach-
ing and assessment throughout the EU is mainly based on tradi-
tional learning methods. Most medical schools do not provide
students with the opportunity to practice real-life prescribing
and do not consider their students to be well prepared for pre-
scribing as a junior doctor.
HOW THIS MIGHT CHANGE CLINICAL
PHARMACOLOGY OR TRANSLATIONAL SCIENCE?
 A collaborative approach should be adopted to harmonize
and modernize the undergraduate CPT education across the
EU.
Prescribing drugs safely and effectively is a fundamental skill that
medical graduates must acquire, because after graduation they
will prescribe drugs on a daily basis, often with minimal supervi-
sion. Inappropriate prescribing may lead to prescribing errors,
resulting in exacerbation or prolongation of illness, patient harm,
and high healthcare costs.1,2 Since graduates from medical schools
in the European Union (EU) are entitled to work in different
EU countries, they should have uniform and adequate prescribing
competencies (i.e., knowledge, skills, attitudes). However, con-
cerns have been expressed that medical graduates across the EU
are not adequately prepared for their prescribing duties.3 In the
UK, recently graduated doctors were found to be responsible
for a large number of prescribing errors and reported not feeling
adequately prepared for their prescribing responsibilities.4,5 Fur-
thermore, a recent multicenter study involving 17 European med-
ical schools showed a general lack of essential prescribing
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competencies among 895 ﬁnal-year students, which has potential
consequences for patient safety.6 Poor undergraduate teaching in
pharmacology and clinical pharmacology and therapeutics (CPT)
may underlie this lack of prescribing competencies.5 Indeed, a
survey conducted under the auspices of the World Health Orga-
nization (WHO) in 1988 showed that European medical schools
devoted relatively little time to teaching clinical pharmacology
and that there was a lack of trained individuals in this area.7
However, it is not known whether the situation has improved in
the meantime, although recent studies showed marked differences
in the quality and quantity of CPT teaching and training
between medical schools in the same country.8,9 Although these
ﬁndings are worrying, a new baseline evaluation is needed to serve
as a starting point for a harmonized CPT curriculum throughout
the EU, as suggested by the British Pharmacological Society
(BPS) and European Association of Clinical Pharmacology and
Therapeutics (EACPT) in 2007.3 Therefore, on behalf of the
Education Working Group of the EACPT, we conducted this
multinational study to gain insight into the current structure,
delivery, and assessment of CPT education in EU medical
schools. Based on the available literature, we hypothesized that
there is marked difference in the quality and quantity of CPT
education between EU medical schools.
RESULTS
From 9 May to 9 November 2016, 290 (95%) out of 304 EU
medical schools were eligible to participate in this study. Luxem-
bourg had only one medical school with a preclinical curriculum
and thus was excluded. Additionally, four schools with a preclini-
cal curriculum (three Belgium, four UK) and nine private medi-
cal schools (one Austria, eight Spain) were excluded. Of all
eligible medical schools, 185 (64%) schools from 27 EU countries
completed the online questionnaire. The mean response rate per
country was 67%, ranging from 14% in Belgium to 100% in the
Czech Republic, Estonia, Lithuania, Malta, the Netherlands, and
Slovenia (see Supplementary Material Table 1).
Figure 1 Only countries with 50% of the medical schools responding are shown. Austria (20%), Belgium (14%), Hungary (25%), and Italy (48%) are not
shown (dark grey). Countries with only problem-based learning education (dark blue; >80% of schools), countries with mainly problem-based learning educa-
tion (light blue; 50–80% of schools), countries with mainly traditional learning education (yellow; 50–80% of schools), countries with only traditional learning
education (orange; >80% of schools). Countries not part of the European Union (light grey). AT, Austria; BE, Belgium; BG, Bulgaria; CY, Cyprus; CZ, Czech
Republic; DE, Germany; EE, Estonia; EL, Greece; ES, Spain; FI, Finland; FR, France; HR, Croatia; HU, Hungary; IE, Ireland; IT, Italy; LT, Lithuania; LV, Latvia; LU,
Luxembourg; MT, Malta; NL, Netherlands; NO, Norway; PL, Poland; PT, Portugal; RO, Romania; SE, Sweden; SI, Slovenia; SK, Slovakia; UK, United Kingdom.
[Color figure can be viewed at wileyonlinelibrary.com]
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The duration of the undergraduate medical curriculum (pre-
clinical and clinical years) ranged from 5 to 6 years. In total, 145
of the medical schools (78%) offered a compulsory course in
CPT, 21 (12%) an elective course, and 19 (10%) offered no
course. Of those schools with a CPT course, 73 (44%) identiﬁed
their course as vertically, 70 (42%) as spirally, and 23 (14%) as
horizontally integrated (see deﬁnitions in Supplementary
Material Figure 1). In all, 176 schools (95%) had a teacher
responsible for CPT. The median number of estimated contact
hours devoted to CPT teaching during the undergraduate curric-
ulum was 68 (interquartile range 35–100). Countries in the east-
ern and southern region of the EU used more traditional
learning methods, whereas countries in the western and northern
region used more problem-based learning methods (Figure 1).
Basic pharmacology was primarily taught and assessed in the early
years of the medical curriculum, whereas clinical pharmacology
and therapeutics was taught in the later years (Supplementary
Material Figure 2).
Teaching methods and study materials
A variety of teaching methods were used (Figure 2). Lectures
(75% (basic pharmacology) to 91% (therapeutics)) and self-study
(57–59%) were the most common teaching methods for CPT,
whereas patient simulation (4–24%) and one-on-one teaching
with a supervisor (2–10%) were the least common methods.
Some medical schools used bedside teaching (43%) and prescrib-
ing in clinics (37%) to teach therapeutics. Lectures (89%) and
clinical cases (81%) were the most common study materials for
CPT education, whereas eBooks (19%) and mobile applications
(13%) were the least common materials (Figure 3).
Teachers involved in teaching development and delivery
In most medical schools, clinical pharmacologists (90%), senior
clinicians who were not clinical pharmacologists (77%), and basic
pharmacologists (74%) developed and delivered CPT education
(Supplementary Material Figure 3). Some schools involved
pharmacists (42%) and junior doctors (36%), and few involved
educational experts (21%) or medical/pharmacy students (8%) in
the development and delivery of their teaching program.
Real-life prescribing in clinics
In most medical schools, students did not get the opportunity to
practice real-life prescribing for patients under the supervision of
a senior clinician on the hospital ward (55%), outpatient clinic
(65%), or general practitioner’s ofﬁce (55%). Moreover, many
respondents did not know whether students had the opportunity
to practice real-life prescribing on the hospital ward (17%), out-
patient clinic (20%), or general practitioner’s ofﬁce (22%).
Assessment methods
A variety of summative assessment methods were used (Figure 4).
Written (73% (basic pharmacology) to 83% (therapeutics)) and
oral examinations (31–40%) were the most common assessment
methods for CPT, whereas student formulary (2–4%) and peer
assessment (1–2%) were the least common methods. Few medical
schools (30%) used practical assessments, such as objective struc-
tured clinical examinations (OSCEs) or workplace assessments in
Figure 2 Traditional learning methods are on the left and context-based learning methods on the right. WHO GGP, World Health Organization Guide to
Good Prescribing.19 Real-life prescribing: the opportunity to prescribe drugs for real patients under the supervision of a senior clinician during clinics. [Col-
or figure can be viewed at wileyonlinelibrary.com]
Figure 3 Written materials are on the left and online learning resources
on the right. Student formulary: specified list of commonly prescribed
drugs that students develop during their medical education. [Color figure
can be viewed at wileyonlinelibrary.com]
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clinics. Most schools did not explicitly assess students’ dosing
knowledge (65%) or drug calculating skills (62%). In contrast to
basic pharmacology (33%), most schools integrated the assessment
of clinical pharmacology (58%) and therapeutics (64%) into a
broader course assessment.
Final prescribing assessment
Eighty-six medical schools (47%) had no ﬁnal prescribing assess-
ment to evaluate ﬁnal-year students’ competencies before gradua-
tion, 42 (23%) participated in a national assessment, 34 (18%)
had a local assessment ranging from written, oral to online exami-
nations, and 23 (12%) had both.
In the UK, a 2-h national online examination (60 multiple-
choice questions (MCQ), extended matching questions (EMQs),
prescribing requests) is used to assess prescribing knowledge and
skills, such as writing prescriptions, reviewing medication, and
calculating drug doses.10 In the Netherlands, a 2-h national
online examination (60 MCQs) focused on ready knowledge
required for safe prescribing is used.11 In both countries, individ-
ual medical schools can decide whether this examination is sum-
mative or formative. In France, prescribing knowledge is assessed
as part of a 2.5-day summative ﬁnal state examination. This
computer-based examination uses narrative patient scenarios (24
cases) combined with MCQs, EMQs, and short answer ques-
tions, some of which relate to CPT.12 In Germany, there is a ﬁnal
state examination involving oral and practical examinations dur-
ing which CPT can be assessed but is not obligatory. In Slovakia,
there is a similar examination but CPT assessment is obligatory.
The remaining countries have no ﬁnal prescribing assessment
before graduation, although in Cyprus, Poland, and Italy thera-
peutic decision-making is evaluated during a compulsory preregis-
tration period after graduation.
Quality, alignment, and structure of learning objectives
In all, 153 medical schools (83%) deﬁned speciﬁc learning objec-
tives for CPT during the undergraduate curriculum, and 63
(41%) submitted their objectives for further evaluation. The mean
overall quality of the objectives was 1.94 (standard deviation (SD)
0.57), with a score of 1.71 (0.73) for “Speciﬁc,” 1.89 (0.75) for
“Measurable,” 1.98 (0.67) for “Achievable,” 1.94 (0.72) for
“Relevant,” and 2.18 (0.90) for “Time-bound.” The objectives of
34 schools (54%) were not or little aligned with the learning and
assessment activities, 19 (30%) were partly aligned, and 10 (16%)
were adequately aligned. Most of the objectives for basic and clinical
pharmacology (93%) and therapeutics (63%) were deﬁned at the
“knows” and “knows how” level of Miller’s pyramid; 36% of the
objectives for therapeutics were deﬁned at the “shows how” level
(Figure 5). The most important themes identiﬁed in the learning
objectives are summarized in Supplementary Material Table 2.
Being prepared for prescribing
Fourteen (8%) respondents described their ﬁnal-year medical stu-
dents as being “not prepared,” 113 (61%) as “fairly well,” 54
(29%) as “well prepared,” and four (2%) as “extremely well pre-
pared” for prescribing as a junior doctor. A common reason for
the lack of preparedness was that the CPT education was too
theoretical, with too little emphasis on training real-life prescrib-
ing in clinical practice (22 free text comments). The probability
of being “well prepared” or “extremely well prepared” rather than
the other qualiﬁcations of preparedness was signiﬁcantly associat-
ed with the presence rather than the absence of a ﬁnal prescribing
assessment (45% vs. 17%, P < 0.0001) and the presence rather
than the absence of a competence assessment of dosing knowl-
edge (41% vs. 27%, P 5 0.048).
Figure 4 The teacher-centered methods are on the left and student-centered methods on the right. OSCE, objective structured clinical examination.
Workplace assessment: assessing rational prescribing for real patients during clinics. [Color figure can be viewed at wileyonlinelibrary.com]
DOES
(action)
SHOWS HOW
(performance)
KNOWS HOW
(competence)
KNOWS 
(knowledge)
Behaviour 
Cognition 
Figure 5 Guide to good prescribing. Miller’s pyramid for evaluating the
structure of learning objectives.
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DISCUSSION
The main ﬁndings of this study are that in the EU 1) CPT edu-
cation varies greatly within and between countries; 2) CPT
teaching and assessment are mainly based on traditional learning
methods; 3) more than two-thirds of the schools do not provide
students with the opportunity to practice real-life prescribing;
4) the assessment of CPT is often integrated into a broader
course assessment, and almost half of the schools do not have a
ﬁnal prescribing assessment; 5) most (69%) medical schools do
not consider their students to be well prepared for prescribing as
a junior doctor; and 6) the overall quality of CPT learning objec-
tives is poor, and objectives are often not consistent with the
learning environment and assessment activities. While there was
some variation between schools, these results suggest that there is
considerable room to improve CPT education in many EU medi-
cal schools.
“Improving and harmonizing the teaching of the rational use
of drugs at both undergraduate and postgraduate levels” in
Europe is a main goal of the EACPT.13 It is important to ensure
a uniform standard of prescribing among medical graduates, so as
to facilitate their mobility across countries. However, we found a
marked variation in the quality and quantity of CPT education
within and between EU countries. Since the last analysis in 1988
showed similar results,7 it is surprising that the situation has not
improved signiﬁcantly. However, despite these large differences,
some progress has been made in the past three decades. First, sev-
eral schools have introduced a distinct or integrated prescribing
assessment before graduation, and having such an assessment was
signiﬁcantly associated with a better perceived preparedness for
prescribing as a junior doctor. A separate and robust prescribing
assessment is necessary to ensure that new doctors are able to pre-
scribe safely and effectively,10 particularly since most schools
Table 1 Scoring rubric for pharmacology and clinical pharmacology and therapeutics learning objectives according to the SMART
criteria
Scorea Specific Measurable Achievable Relevant Time-bound
15 Poor  Broad, vague and
unclear objectives
 Not specific to drug
groups, themes or core
drugs and diseases
that students should
be familiar with
 Objectives are not
clearly measurable
and documentable
 Objectives are not or
hardly feasible given
student’s abilities and
will likely not be
achieved within the
designated time frame
 Objectives cover no or
little relevant knowl-
edge, skills, and atti-
tudes for CPT
 No or unclear time
frame by which the
objectives should be
accomplished
25 Suboptimal  Specific objectives, but
does not specify knowl-
edge, skills and atti-
tudes in detail
 Specified list of
themes/drug groups
(e.g. cardiovascular
drugs) that students
should be familiar with
but no list of core
drugs and diseases
 Uses verbs like under-
stand, know, learn,
list, describe and
explain
 Objectives are only
partly measurable and
documentable
 Objectives are partly
feasible given the stu-
dent’s abilities and
can only partially be
achieved within the
designated time frame
 Objectives cover some
relevant knowledge,
skills, and attitudes for
CPT
 A clear time frame of
what should be accom-
plished within the
bachelor’s or master’s
degree or undergradu-
ate curriculum
35 Adequate  Specific objectives
with a detailed descrip-
tion of the required
knowledge, skills and
attitudes for CPT
 Specified list of core
drugs and diseases
that students should
know about
 Describes what the
student should be able
to do in clinical
practice
 Uses action verbs like
prescribe, choose,
show, select, review
(NOT understand,
learn, know)
 Objectives are clearly
measurable and
documentable
 Objectives are feasible
given the student’s
abilities and can be
achieved within the
designated time frame
 Objectives cover most
of the relevant knowl-
edge, skills, and atti-
tudes for CPT
 A clear time frame of
what should be accom-
plished within a
course, module,
semester or academic
year
Based on the SMART mnemonic.27 Adapted from Lockspeiser et al.28 CPT, pharmacology and clinical pharmacology and therapeutics.
aScore per criteria ranged from 1 to 3, with no half points. If objectives did not meet the requirement for a particular score, it received the next lower score.
ARTICLES
CLINICAL PHARMACOLOGY & THERAPEUTICS | VOLUME 102 NUMBER 5 | NOVEMBER 2017 819
integrated the assessment of CPT into a broader course assess-
ment, and hence students can compensate for a poor perfor-
mance in this area by a good performance in other areas.
Although the development of ﬁnal prescribing assessments is
promising, future studies should investigate whether these actual-
ly improve prescribing objectives after graduation.
Second, more medical schools had an identiﬁable CPT course
(90% in 2016 vs. 77% in 1988), and, on average, more contact
hours per school were devoted to CPT education during the
undergraduate curriculum (95 h in 2016 vs. 35 h in 1988).
Although these ﬁndings are encouraging, relatively few hours are
devoted to CPT education (62–3% of total study load) com-
pared with other, mainly diagnostic, subjects. Curriculum design-
ers tend to place more emphasis on diagnostic rather than
therapeutic reasoning, with the former being perceived as more
challenging and difﬁcult.14 Consistent with the views of ﬁnal-
year students in Europe,6 CPT education was mainly based on
traditional learning methods such as lectures and written exami-
nations, rather than on context-based learning methods, such as
patient simulation and workplace assessments. In fact, a large pro-
portion (39%) of schools used solely traditional learning meth-
ods, which could in part explain why respondents indicated that
students were not well prepared for rational prescribing. The pre-
dominance of traditional learning methods in pharmacology edu-
cation has also been reported in the USA.15 Rational prescribing
is a complex skill that requires various high-level cognitive pro-
cesses,16 and thus attending lectures and passing written examina-
tions probably do not prepare students sufﬁciently for this task.
A recent study showed that students taught with mainly tradi-
tional learning curricula have signiﬁcantly weaker prescribing
competencies than students taught with mainly problem-based
learning curricula.6 The WHO Guide to Good Prescribing
model has been shown to be the only effective method to teach
rational prescribing in a wide variety of international set-
tings,17–19 yet fewer than 20% of the respondents used this model
in their teaching program. This could be because these medical
schools provide little practical teaching in the form of role-
playing sessions and patient simulation, for which this model is
best suited. Although a transition towards more practical teach-
ing is necessary, the resource-intensive format of this teaching
could be a challenge for medical schools with a small group of
CPT teachers. The traditional aspect of CPT education is also
reﬂected by the extensive use of written materials compared with
online learning resources such as E-learning, eBooks, and mobile
applications. More medical schools should use and share these
online resources because they increase accessibility to informa-
tion, facilitate personalized training, standardization of content,
and are suitable for assessing large cohorts of students
simultaneously.20
Third, more schools had a designated teacher responsible for
CPT education (95% in 2016 vs. 79% in 1988), often a clinical
pharmacologist or senior clinician. Such an individual is indis-
pensable for ensuring that the principles of safe and effective use
of medicines are emphasized throughout the curriculum.21 Only
a minority of schools actively involved junior doctors and
medical/pharmacy students in teaching and education. Yet “near-
peer” education has proven to be beneﬁcial and able to reduce
the workload of the usually small group of teachers.22 Clinical
pharmacists and nurse prescribers should be given a larger role as
educators since they offer additional skills and attributes (e.g.,
reviewing medication charts) and could improve interdisciplinary
collaboration for the prevention of prescribing errors.23,24
The quality of CPT learning objectives was generally poor,
with objectives often being broad, vague, and incomplete. Only
Table 2 Recommendations to harmonize and modernize pharmacology and clinical pharmacology and therapeutics education in the
curricula of medical schools in the European Union
1. CPT should be a clear and visible program throughout the entire medical curriculum, starting as early as possible, and should be emphasized in all
clinical modules and attachments.21,30
2. Prescribing should be trained in simulated and clinical environments, with emphasis on completing drug prescriptions, reviewing medication charts,
and real responsibility for patient care.16,21
3. Schools should formulate clear and specific learning objectives, preferably using a detailed list of core drugs (‘student formulary’) and diseases
that students should be familiar with before graduation.21,30
4. Schools should ensure that learning objectives are compatible with the learning environment and assessment activities.
5. The WHO ‘Guide to Good Prescribing’ should be used more intensively in order to teach and train rational prescribing.17–19
6. Schools should utilize more online learning resources and preferably share these at national or international level.20
7. Medical/pharmacy students and junior doctors should be engaged in ‘near peer’ education, supervised and trained by clinical pharmacologists and
senior clinicians.22
8. Clinical pharmacists and nurse prescribers should be given a greater role in the development and delivery of CPT education.23,24
9. Schools should implement a robust and separate CPT assessment structure throughout the curriculum, with no compensatory mechanism.21
10. Schools should implement a valid and reliable final prescribing assessment at or near the end of the medical curriculum to assess whether gradu-
ates are able to prescribe safely and effectively.10,11
11. Prescribing should be assessed in a simulated or clinical context, with emphasis on writing prescriptions, verifying the suitability of the treatment
choice, giving information to patients, and drug monitoring.21,30
Corresponding references are given; CPT, pharmacology and clinical pharmacology and therapeutics.
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13 schools used a speciﬁed list of core drugs and diseases that stu-
dents should be familiar with before graduation. Clear objectives
are important to verify whether learning outcomes are achieved.21
Therapeutic objectives were often focused on skills acquisition
(e.g., rational prescribing, see Supplementary Material Table 2)
but did not dovetail with the learning environment (e.g., lectures)
and assessment activities (e.g., written examinations). Better coor-
dination between learning objectives and curriculum content is
necessary to help students achieve high-level outcomes.25
Our results should be interpreted in the light of some limita-
tions. First, data were mainly derived from a single teacher at
each school and may have been biased either because the respond-
ents had vested interests or interpreted the questions differently.
Second, although deﬁnitions were given, there may have been
some overlap between CPT themes in the questionnaire. Third,
since the questionnaire was not anonymous, respondents may
have given socially desirable answers. Fourth, the low response
rate in some countries (i.e., Austria, Belgium, Hungary, Italy)
might have inﬂuenced the results. Fifth, the participating medical
schools might have a high standard of CPT education, and thus
the results might be optimistic. Sixth, we relied on medical
schools to self-report their education, which may not reﬂect the
actual content of the medical curriculum. Seventh, students
might be offered other learning activities, which are outside the
remit of the responsible teachers and thus not reported in the
questionnaire.
CONCLUSIONS AND RECOMMENDATIONS
Although some progress has been made in the past three decades,
this study showed that there is still marked variation in the quali-
ty and quantity of CPT education within and between EU coun-
tries. This ﬁnding may underlie the general lack of prescribing
competencies among European medical graduates. Since gradu-
ates from medical schools in the EU can move to different EU
countries for their postgraduate training, they should have a uni-
form level of prescribing competencies. In order to achieve this, a
collaborative effort is required to harmonize and modernize the
teaching and assessment of the rational use of drugs at an under-
graduate level. The EACPT Education Working Group has for-
mulated a list of recommendations that can serve as starting
point for a harmonized CPT curriculum for EU medical schools
(Table 2).
METHODS
This cross-sectional survey involved medical schools in all 28 EU coun-
tries and was carried out in the academic year 2015–2016. Since we
focused on CPT education during the entire medical curriculum, we
excluded medical schools delivering only a preclinical curriculum (i.e.,
bachelor’s degree). Additionally, we excluded private medical schools
because their education is not accessible for all students. A 24-item web-
based questionnaire (using surveymonkey.com) was developed, based
on comparable studies,7–9,26 and validated by the Education Working
Group of the EACPT during an online modiﬁcation round (Supple-
mentary Material Figure 1). The questionnaire asked speciﬁc questions
about undergraduate teaching and assessment of basic pharmacology,
clinical pharmacology and therapeutics, and the preparedness of students
for their future task as prescribers. Basic pharmacology was deﬁned as
education about the basic principles of how drugs act in biological
systems including pharmacodynamics (e.g., receptor and other drug tar-
gets), pharmacokinetics (e.g., absorption, distribution, metabolism, excre-
tion), and pharmacogenetics; clinical pharmacology as education about
the application of pharmacological principles and methods in clinical
practice (e.g., rational drug selection, adverse drug reactions, drug interac-
tions, errors, adherence); therapeutics as education about the process of
rational prescribing for speciﬁc clinical conditions (i.e., how to choose a
speciﬁc drug for an individual patient). Explanations to the questions
were provided where appropriate, with opportunity for free text com-
ments. Minor modiﬁcations to the content were made after a pilot study
with eight CPT teachers from different EU medical schools. The Dutch
Ethics Review Board of Medical Education approved the study
(Approved Project no. NVMO-ERB 651). Informed consent was
obtained from all participants.
A representative from the EACPT Network of Teachers in Pharma-
cotherapy (NOTIP) was purposely selected from each country to coordi-
nate the survey in his or her country. NOTIP is a European platform for
medical schools and CPT teachers. It supports the development and
sharing of teaching materials and participation in joint research projects.
Each coordinator collected the email addresses of the teacher(s) responsi-
ble for undergraduate CPT education at each medical school. If neces-
sary, the national (clinical) pharmacological societies were asked to
supply missing contact details. A web link to the questionnaire was e-
mailed to the responsible teacher(s) and e-mail reminders were sent 2
and 4 weeks after the initial message. Participation was voluntary and
without compensation; conﬁdentiality was guaranteed. The question-
naire took 15 min to complete. If more than one teacher per school
completed the questionnaire, answers were integrated into a ﬁnal version
by the main researcher (D.B.). Based on the survey data, the research
team assessed whether CPT education at each school was based on tradi-
tional learning or problem-based learning methods. Traditional learning
was deﬁned as >50% of the teaching methods consisted of lectures (for-
mal), self-directed learning (textbooks), oral and written exams and
essays; and problem-based learning as >50% of the teaching methods
consisted of seminars (interactive), small working groups (case scenarios),
role playing and patient simulation including OSCEs, clinics including
prescribing for real patients. Subsequently, countries with 50% of the
schools responding were categorized as “only” (>80%) or “mainly” (50-
80%) problem-based learning, or “mainly” (50-80%) or “only” (>80%)
traditional learning (Figure 1).
After completion of the questionnaire, each school was asked to send
the undergraduate learning objectives for CPT. The overall quality of
these objectives was assessed by the research team using a scoring rubric
adapted from the literature (Table 1).27,28 Also, the alignment with the
learning and assessment activities during the curriculum were evaluated
(1 5 no or little alignment, 2 5 some alignment, 3 5 adequate align-
ment) and the general themes were identiﬁed (Appendix Table 2).
Additionally, each objective was categorized into one of the four levels of
Miller’s pyramid (i.e., “knows,” “knows how,” “shows how,” “does”; Fig-
ure 5).29 Completed questionnaires were downloaded in Excel format
and analyzed using SPSS v. 22.0 (Chicago, IL). The v2 for independence
was used to detect statistically signiﬁcant relationships between two cate-
gorical variables.
Additional Supporting Information may be found in the online version of
this article.
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